Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2014

Open Access 01.12.2014 | Research

Laparoscopic versus open resection for gastric gastrointestinal stromal tumors: an updated systematic review and meta-analysis

verfasst von: Qi-Long Chen, Yu Pan, Jia-Qin Cai, Di Wu, Ke Chen, Yi-Ping Mou

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2014

Abstract

Background

In past decades, laparoscopic surgery has been introduced for the treatment of gastrointestinal stromal tumors (GISTs). Recently, additional studies comparing laparoscopic versus open surgery for gastric GISTs have been published, and an updated meta-analysis of this subject is necessary.

Methods

A systematic search was conducted in PubMed, Embase, Cochrane Library, and Web of Science. Comparative studies of laparoscopic and open surgery for gastric GISTs published before June 2014 were identified from databases. The Newcastle-Ottawa Quality Assessment Scale was used to perform quality assessment and original data were extracted. The statistical software STATA (version 12.0) was used for the meta-analysis.

Results

Finally, 22 studies, including a total of 1,166 cases, meet the inclusion criteria for meta-analysis. The operation time was similar between laparoscopic and open surgery. Compared to open surgery, laparoscopic resection was associated withless blood loss (WMD = -58.91 ml; 95% CI, -84.60 to -33.22 ml; P <0.01); earlier time to flatus (WMD = -1.31 d; 95% CI, -1.56 to -1.06, P <0.01) and oral diet (WMD = -1.75 d; 95% CI, -2.12 to -1.39; P <0.01); shorter hospital stay (WMD = -3.68 d; 95% CI, -4.47 to -2.88; P <0.01); and decreased overall complications (relative risk = 0.57; 95% CI, 0.37 to 0.89; P = 0.01). For long-term outcomes, there were no significant differences between two surgical procedures on recurrence.

Conclusion

Laparoscopic surgery for gastric GISTs is acceptable for selective patients with better short-term outcomes compared with open surgery. The long-term survival situation of patients mainly depends on the nature of tumor itself, and laparoscopic surgery was not associated with worse oncological outcomes.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-12-206) contains supplementary material, which is available to authorized users.
Qi-Long Chen, Yu Pan contributed equally to this work.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

QLC and YP wrote the manuscript; JQC, DW and KC performed the literature review and conducted the analysis of pooled data; YPM proofread and revised the manuscript. All authors read and approved the final manuscript.
Abkürzungen
CI
confidence interval
GISTs
gastrointestinal stromal tumors
LAP
laparoscopic surgery
NOS
Newcastle-Ottawa Quality Assessment Scale
OPEN
open surgery
RCTs
randomized controlled trials
RR
relative risk
WMD
weighted mean difference.

Background

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor in the gastrointestinal tract and are often characterized by cellular markers, such as CD117 (a c-kit gene proto-oncogene product) and CD34 (a human progenitor cell antigen) [13]. GISTs, which frequently occur in the stomach and small intestine [2], have malignant potential, and recurrence of GISTs often occurs at the peritoneal surface or liver [4]. Targeted therapies have been developed for GISTs, but surgical resection remains the optimal initial treatment approach for primary GISTs with no evidence of metastasis. The surgical principles of gastrointestinal stromal tumor comprise en bloc resection (R0 resection) with avoidance of rupture, which may result in peritoneal seeding. In addition, lymphadenectomy is not indicated in GISTs because of a very low propensity for lymph node metastases [5].
With the development of minimally invasive surgical approaches, laparoscopic surgery (LAP) for gastrointestinal stromal tumors has evolved rapidly over the past decades. Various types of laparoscopic approaches for GISTs have been performed in a few specialized centers, including wedge resection of the stomach, intragastric tumor resection, and combined endoscopic-laparoscopic resection [69]. Owing to the technique difficulty and relative rarity of GISTs, there is few study of large scale of patients reporting the short- and long-term results for LAP for GISTs compared with open surgery (OPEN). To address these issues, our team conducted the following meta-analysis to compare short-term and long-term results of patients undergoing LAP.

Methods

Search strategy

A systematic search was conducted in PubMed, Embase, Cochrane Library, and Web of Science to identify articles published up to June 2014. The search terms included ‘gastrointestinal stromal tumor’, ‘GIST’, ‘laparoscop*’, ‘gastrectomy’ and “gastric resection’. A personal search was also performed with reference lists of the retrieved relevant articles and reviews to identify additional trials and ensure that all the potential studies were included. The language of the articles was limited to English and Chinese according to the reviewers’ language competence.

Study selection

The inclusion criteria were as follows: comparative, peer-reviewed studies of LAP versus OPEN for GISTs for which the full text of the article was available. If two or more studies from the same institution, the most recent study or that including informative data was selected unless the reports were from different time periods. We excluded studies including: GISTs out of the stomach; complicated with mixed disease, such as gastric cancer; studies in which fewer than two relevant indexes were reported, or where it was difficult to calculate these from the results; and studies where the measured outcomes were not clearly presented in the literature.

Data extraction and quality assessment

Two researchers independently extracted the data and disagreement was resolved through discussion. Extracted data included author, study period, geographical region, number of patients, operation time, blood loss, time to flatus, time to oral intake, length of hospital stay, morbidity, mortality, and long-term outcomes. The Newcastle-Ottawa Quality Assessment Scale (NOS) was used as an assessment tool. This scale varies from zero to nine stars: studies with a score equal to or higher than six were considered methodologically sound.

Outcome definition and Statistical analysis

Postoperative complications were classified as systematic complications (cardiovascular, respiratory or metabolic events; nonsurgical infections; deep venous thrombosis; and pulmonary embolism) or surgical complications (any anastomotic leakage or fistula, any complication that required reoperation, intra-abdominal collections, wound complications, bleeding events, pancreatitis, ileus, delayed gastric emptying, and anastomotic stricture). This classification system is based on the Memorial Sloan-Kettering Cancer Center complication reporting system [10]. Continuous variables were assessed using weighted mean difference (WMD), and dichotomous variables were analyzed using the risk ratio (RR). If the study provided medians and ranges instead of means and standard deviations, we estimated the means and standard deviations as described by Hozo et al. [11]. Statistical heterogeneity was evaluated by the Higgins I2 statistic [12]. Based on method reported by DerSimonian and Laird [13], substantial significance was set when P < 0.10 and a random effect model was used. We hypothesized the outcomes of the comparison may be affected by the uneven distribution of the surgical types between the LAP and OPEN groups, especially by the relatively larger proportion of extended surgeries performed in the OPEN group. Thus, we performed a subgroup analysis of patients who underwent wedge resection in the two groups to eliminate the bias from the surgical type selection. We also conducted a subgroup analysis of studies that had comparable tumor size or risk index proposed by Fletcher et al. [3], which may have an impact on the operative outcomes. The potential publication bias based on the postoperative complications was assessed Begg’s test and funnel plots. Data analyses were performed using STATA (version 12.0). P <0.05 was considered statistically significant.

Results

Studies selected

By the initial search, 768 potentially relevant articles were identified. After the titles and abstracts were reviewed, papers without comparison of LAP and OPEN were excluded, which left 28 comparative studies. An additional six [1419] studies did not meet the inclusion criteria and were excluded. In total, 22 observational studies were obtained [2041], all of which were accessible in full-text format. Twenty-one studies were published in English and one in Chinese. A flow chart of the search strategies, which contains reasons for exclusion, is presented in Figure 1.

Characteristics and quality of studies

A total of 1,166 patients were included in the analysis with 574 undergoing LAP (49.2%) and 592 undergoing OPEN (50.8%). They represented an international experience, with data included from 10 different countries or regions (six Japan, four United States, four China, two Korea, one United Kingdom, one Italy, one Belgium, one Austria, one Singapore and one Taiwan). According to the NOS, one out of the 22 observational studies got six stars, six articles got seven stars, eight articles got eight stars and the remaining seven got nine stars. Overall, all studies were evaluated as being moderate to high quality. The characteristics and methodological quality assessment scores of the included studies are summarized in Table 1.
Table 1
Summary of studies included in the meta-analysis
Author
Region
Study design
Year
Study period
Sample size
Conversion (%)
Follow-up (month)
Recurrence
Quality scores
     
LAP
OPEN
 
LAP
OPEN
LAP
OPEN
 
Shimizu et al. [20]
Japan
OCS (R)
2002
1986-2000
11
8
0
NR
NR
NR
NR
7
Matthews et al. [21]
USA
OCS (R)
2002
1994-2000
21
12
NR
20
18
1
1
7
Ishikawa et al. [22]
Japan
OCS (R)
2006
1993-2004
14
7
NR
60 (5 to 119)
61 (3 to 130)
2
1
8
Mochizuki et al. [23]
Japan
OCS (R)
2006
2000-2004
12
10
NR
26 (6 to 53)
NR
0
0
8
Nishimura et al. [24]
Japan
OCS (R)
2007
1993-2004
39
28
2.6
18.9 (2.6 to 96.4)
31.2 (4.4 to 121.9)
1
4
9
Pitsinis et al. [25]
UK
OCS (P)
2007
2004-2006
6
7
NR
9
9
0
0
6
Catena et al. [26]
Italy
OCS (P)
2008
1995-2006
21
25
NR
35 (5 to 58)
91 (80 to 136)
0
1
9
Silberhumer et al. [27]
Austria
OCS (R)
2009
1998-2006
22
41
18.2
30 ± 20
41 ± 31
0
4
8
Goh et al. [28]
Singapore
OCS (R)
2010
2001-2009
14
39
7.1
8 (3 to 60)
21(2 to 72)
0
2
7
Karakousis et al. [29]
USA
OCS (P)
2011
1998-2009
40
40
22.5
28 (0.3 to 70)
43 (0.1 to 139)
1
1
9
Dai et al. [30]
China
OCS (R)
2011
2000-2009
18
30
NR
78
64
2
3
9
De Vogelaere et al. [31]
Belgium
OCS (P)
2012
1997-2011
37
16
NR
83 (2 to 163)
71 (0.3 to 199)
0
6
8
Melstrom et al. [32]
USA
OCS (P)
2012
1999-2008
17
29
5.9
32
59
0
4
7
Lee et al. [33]
Korea
OCS (R)
2011
2001-2008
50
50
2
21.1 (0 to 64)
22.3 (0 to 93)
0
0
9
Wan et al. [34]
China
OCS (R)
2012
2004-2011
68
88
NR
29 (4 to 89)
36 (4 to 90)
3
4
9
Pucci et al. [35]
USA
OCS (P)
2012
2002-2012
57
47
1.8
NR
NR
NR
 
7
Kim et al. [36]
Korea
OCS (R)
2012
1998-2011
24
14
NR
62.6 (8.9 to 164.4)
58.3 (18.8 to 123.2)
1
3
7
Shu et al. [37]
China
OCS (R)
2013
2010-2012
15
21
NR
NR
NR
N
NR
8
Lee et al. [38]
Taiwan
OCS (R)
2013
2007-2009
30
32
NR
NR
NR
NR
NR
8
Kasetsermwiriya et al. [39]
Japan
OCS (R)
2014
1988-2011
23
10
NR
46 (2 to 168)
19 (1 to 275)
0
1
8
Lin et al. [40]
China
OCS (R)
2014
2007-2012
23
23
4.3
34 (6 to 78)
2
3
9
Takahashi et al. [41]
Japan
OCS (R)
2014
1995-2011
12
15
25
57 (7 to 120)
69 (13 to 154)
1
2
8
LAP, laparoscopic surgery; NR, not reported; OCS, observational clinical study; OPEN, open surgery; P, prospectively collected data; R, retrospectively collected data.

Comparison of operative outcomes

The tumor size for LAP was significantly smaller than that for OPEN (WMD = -0.98 cm; 95% CI, -1.36 to -0.60; P <0.01; Figure 2). The present analysis showed no statistically significant difference in the operation time of the two groups (WMD = -11.22 min; 95% confidence interval (CI), -28.66 to 6.23; P = 0.21; Figure 3). Intraoperative blood loss was significantly lower in the LAP compared with the OPEN group (WMD = -58.91 ml; 95% CI, -84.60 to -33.22 ml; P <0.01; Figure 4).

Comparison of short-term postoperative outcomes

The outcomes also favored LAP in first flatus day (WMD = -1.31 d; 95% CI, -1.56 to -1.06; P <0.01; Figure 5) and first oral intake (WMD = -1.75 d; 95% CI, -2.12 to -1.39; P <0.01; Figure 6). Moreover, postoperative hospital day was 3.68 days shorter for LAP patients (WMD = -3.68 d; 95% CI, -4.47 to -2.88; P <0.01; Figure 7). With respect to the rate of overall postoperative complications, LAP is significantly superior to OPEN. The rate of overall postoperative complications was significantly lower for LAP (RR = 0.57; 95% CI, 0.37 to 0.89; P = 0.01; Figure 8). After further analysis, surgical complications were similar between the two groups (RR = 0.69; 95% CI, 0.37 to 1.29; P = 0.24). However, LAP was associated with a marginal reduction in systematic complications (RR = 0.57; 95% CI, 0.32 to 1.04; P = 0.07).

Comparison of oncological outcomes

15 studies reported tumor recurrence [21, 22, 24, 2632, 34, 36, 3941]. The recurrence risk in LAP was 3.6% (14 out of 388) and 9.7% (38 out of 393) in OPEN, and patients who underwent LAP were less likely than the OPEN group to have recurrence (RR = 0.51; 95% CI, 0.28 to 0.93; P = 0.03; Figure 9). The available data about recurrence patterns and survival outcomes are summarized in Table 2.
Table 2
Summary of the available data about recurrence patterns and survival outcomes
Case
Group
Risk
Recurrence
Survival
Case
Group
Risk
Recurrence
Survival
Case
Group
Risk
Recurrence
Survival
[21]
LAP
High
NR
Dead
[26]
OPEN
NR
NR
Dead
[31]
OPEN
High
6 m Liver
52 m Alivea
[21]
OPEN
High
NR
14 m Dead
[27]
OPEN
High
Local
Deadb
[31]
OPEN
High
9 m Liver
75 m Alivea
[22]
LAP
High
Liver
32 m Dead
[27]
OPEN
High
Local
Alivea
[31]
OPEN
High
21 m Liver
16y Deada
[22]
OPEN
High
Liver
9 m Dead
[27]
OPEN
High
Liver
Alivea
[36]
OPEN
High
52 m Peritoneal
Deada
[22]
LAP
Low
Local
Alive
[27]
OPEN
High
Multiple
Alivea
[36]
OPEN
High
60 m Liver
Alive
[24]
LAP
Low
33 m Local
Alive
[29]
LAP
High
Peritoneal
4 y Alive
[36]
OPEN
High
6 m Colon
Deada
[24]
OPEN
High
7 m Peritoneal
Alive
[29]
OPEN
Moderate
Liver
10 y Alive
[36]
LAP
High
31 m Stomach
Alive
[24]
OPEN
High
53 m Local
Alive
[31]
OPEN
High
4 m Liver
28 m Deada
[36]
OPEN
High
15 Peritoneal
Deada
[24]
OPEN
High
37 m Liver
Alive
[31]
OPEN
High
10 m Liver
Alivea
[39]
OPEN
High
11 m Liver
59 m Alive
[24]
OPEN
High
15 m Multipled
Alive
[31]
OPEN
High
42 m Liver
46 m Deada,c
     
LAP, laparoscopic surgery; m: month; NR, not reported; OPEN, open surgery; y: year.
atreated with imatinib; bdue to cardiac insufficiency; cdue to lung cancer; dincluded liver and local recurrence.

Comparison of wedge resection

Comparison data of laparoscopic wedge resection and open wedge resection was available in eight studies[20, 22, 23, 26, 28, 30, 33, 34]. The overall effects such as operation time, blood loss, time to flatus or oral intake, hospital stay, and complications remained unchanged. However, in this subgroup analysis, the recurrence risk in LAP was 5.4% (7 out of 130) and 5.5% (9 out of 165) in OPEN, and the difference was not significant (RR = 1.01; 95% CI, 0.39 to 2.63; P = 0.99). The outcomes of subgroup analysis for studies of wedge resection are summarized in Table 3.
Table 3
Pooled outcomes of subgroup analysis for studies of wedge resection
Outcomes
Number of studies
Sample size
Heterogeneity (P, I 2 )
Overall effect size
95% CI of overall effect
P
  
LAP
OPEN
    
Operation time (min)
8
203
233
<0.001, 82%
WMD = 12.03
-8.03, 32.09
0.24
Blood loss (ml)
5
118
151
0.03, 64%
WMD = -48.29
-78.23, -18.36
<0.01
Time to first flatus (d)
6
119
144
0.10, 46%
WMD = -1.35
-1.66, -1.03
<0.01
Time to oral intake (d)
7
182
208
0.001, 73%
WMD = -1.67
-2.19, -1.15
<0.01
Hospital stay (d)
8
203
233
0.002, 68%
WMD = -2.53
-3.50, -1.57
<0.01
Overall complications
8
203
233
0.70, 0%
RR = 0.47
0.22, 1.01
0.05
Tumor size (cm)
8
203
233
0.10, 42%
WMD = -0.77
-1.23, -0.31
<0.01
Recurrence
5
130
165
0.95, 0%
RR = 1.01
0.39, 2.63
0.99
CI, confidence interval; LAP, laparoscopic surgery; OPEN, open surgery; RR, risk ratio; WMD, weighted mean difference.

Subgroup analysis for studies with comparable tumor size or risk index

Thirteen studies qualified for a subgroup analysis for studies with comparable tumor size or risk index [20, 21, 23, 24, 26, 29, 30, 33, 34, 3740]. Like the subgroup analysis for wedge resection, outcomes other than tumor recurrence remained unchanged. The recurrence risk was similar between LAP and OPEN (RR = 0.66; 95% CI, 0.31 to 1.42; P = 0.29). The outcomes of subgroup analysis for studies with comparable tumor size or risk index are summarized in Table 4.
Table 4
Pooled outcomes of subgroup analysis for studies with comparable tumor size or risk index
Outcomes
Number of studies
Sample size
Heterogeneity (P, I 2 )
Overall effect size
95% CI of overall effect
P
  
LAP
OPEN
    
Operation time (min)
13
371
377
<0.001, 81%
WMD = -1.06
-16.93, 14.81
0.90
Blood loss (ml)
11
300
302
<0.001, 71%
WMD = -58.20
-81.76, -34.65
<0.01
Time to first flatus (d)
6
129
142
0.09, 47%
WMD = -1.28
-1.60, -0.97
<0.01
Time to oral intake (d)
7
212
241
0.02, 61%
WMD = -1.77
-2.18, -1.35
<0.01
Hospital stay (d)
11
309
339
0.006, 60%
WMD = -2.87
-3.54, -2.21
<0.01
Overall complications
12
341
345
0.74, 0%
RR = 0.49
0.30, 0.81
<0.01
Tumor size (cm)
13
371
377
0.23, 21%
WMD = -0.57
-0.86, -0.29
<0.01
Recurrence
8
248
232
0.81, 0%
RR = 0.66
0.31, 1.42
0.29
CI, confidence interval; LAP, laparoscopic surgery; OPEN, open surgery; RR, risk ratio; WMD, weighted mean difference.

Publication bias

To test for publication bias, we used funnel plots and performed an Egger’s test based on the incidence of overall postoperative complications (Figure 10). The graphical funnel plot showed that none of the studies lay outside the 95% CI boundaries, and there was no evidence of publication bias.

Discussion

GISTs, although rare, are the most common mesenchymal tumors arising in the wall of the gastrointestinal tract. Surgery remains the mainstay of definitive therapy for non-metastatic GISTs. Recent evidence suggests that prognosis is mainly based on tumor size and histological features rather than wide resection margins [3, 42], which makes laparoscopic resection more popular for GIST treatment. Recently, some meta-analysises showed the superiority of LAP to OPEN [43, 44]. With the development of the laparoscopic technique, several additional articles that compare LAP with OPEN have been published since that analysis [3641]. Therefore, we performed this updated meta-analysis to broaden the current knowledge on the clinical value of LAP.
We failed to include randomized controlled trials (RCTs) in this study. Although RCTs are first choice for a high-quality of meta-analysis, there are some hurdles to overcome such as learning curve effects, ethical issues, and the relatively low incidence of GISTs during the conduction of a high-quality RCT to evaluate this new surgical approach. Therefore, we made a number of efforts to ensure convincing results from non-RCTs, including the use of NOS to assess the quality of the studies and exclude low-quality studies; conducting subgroup analysis for studies of wedge resection, comparable tumor size or risk index to minimize the selection bias; and using funnel plots and Egger’s test to detect publication bias.
Our pooled analysis demonstrated faster gastrointestinal recovery in LAP. Reduced use of analgesic drugs, milder acute inflammatory response, and earlier postoperative activities are considered to be the main reasons for earlier gastrointestinal recovery in this type of surgery. The meta-analysis demonstrated a reduced number of complications in the LAP versus OPEN group, which may have resulted from a reduction in systematic complications. It is conceivable that surgical complications were similar between groups because LAP, though less invasive, results in the same resection extent as OPEN. Decreased pulmonary infection, which is the most common systemic complication, could explain the reduced systemic complications in LAP. Pain after surgery was less serious in LAP than in OPEN, reflected by a shorter duration or lower dosage of analgesics. The pain caused by the large incision as well as the use of tension sutures and abdominal bandages after laparotomy would deter patients’ attempts to cough, expectorate and perform breathing exercise effectively, resulting in complications such as pulmonary infection [45]. Our study demonstrated the postoperative hospital stay was 3.6 days shorter for LAP patients, which reasonably results from faster gastrointestinal recovery and a reduced number of complications in LAP.
The present analysis demonstrated that the operative time in the LAP group was similar to OPEN, which is in contrast to many other types of gastrointestinal surgery [4649]. This result was mainly based on two factors. Lymphadenectomy, which is complicated and time-consuming under laparoscopy, is not generally required in LAP. Time spent on the establishment of pneumoperitoneum and the closure of the trocar incision and mini-laparotomy is likely to be shorter than the opening and closing of a laparotomy. Additionally, most studies involving less operative time in the LAP group had a relatively larger sample size or were recently published [29, 3341], which might explain why the LAP appeared to be shorter than OPEN because of an accumulation of laparoscopic skills and the development of laparoscopic instruments.
Operative blood loss was shown in the pooled analysis to be lower in LAP. The reduced length of incision and the application of energy-dividing devices contribute to this reduction in blood loss. Moreover, the magnified view of laparoscopy allows for meticulous manipulation and reduction of injury. In our study, the asymmetric distribution of tumor size or extent of resection makes comparison of operative blood loss inherently flawed and at a high risk for confounding factors. So a subgroup analysis for studies with comparable tumor size or extent of resection was conducted, and less operative blood loss was still observed, which suggests that the technique of LAP itself might be the main reason for less operative blood loss.
Long-term survival remains critical for patients with GIST because of its malignant potential. Our study confirmed the safety of LAP for GISTs compared with OPEN. The postoperative recurrence in the LAP group was less than that of the OPEN group with statistical significance. However, the observed advantages of laparoscopy may be skewed by selection bias regarding tumor size. In several included studies, larger tumor size and higher risk classification were dominant in the OPEN group. According to the risk assessment classification [3], tumor size and mitotic index are two key factors on GISTs long-term outcomes. Thus, the studies with the same surgical approach (wedge resection) as well as those with comparable tumor size or risk classification were included in a subgroup analysis. The results of two subgroup analyses showed that the risk of postoperative recurrence in the LAP group was similar to the OPEN group. The increased experience of laparoscopic procedures, no touch of tumor and retrieving the tumor with an endobag [8, 36] may have contributed to this result. In addition, we also observed that the common sites of postoperative recurrence of GISTs included liver metastasis, peritoneal metastasis and local recurrence. Most cases of recurrence or metastasis had a trend toward higher-risk profiles and no port metastasis was identified, which suggests tumor recurrence is not clearly related to the surgical approach [21, 22, 24, 26, 27, 29, 31, 36, 39].
There are several limitations to our studies that must be taken into account when considering the results. First, all of the studies included in this meta-analysis are non-RCTs, which could lead to substantial selection and observation bias. Second, despite the majority of studies analyzed focusing only on GISTs, some included studies had several cases of other types of gastric submucosal tumors, such as neurilemmomas and leiomyomas. Because the sample size of remaining studies was still small for definitive conclusions on the safety and effectiveness of LAP, we did not exclude the study. Although such a low number does not imply a significant bias, it still can lead to clinical heterogeneity. Third, although the funnel plot showed that publication bias is unlikely, clinicians must be aware of possible publication bias when using evidence in clinical practice. Also, the follow-up duration of cases in the meta-analysis is too short for the low-risk GISTs to have developed tumor recurrence, which may have an influence on the tumor recurrence rate, and more long-term follow-up studies are awaited.

Conclusions

The current clinical evidence revealed that LAP is safe and feasible for the treatment of gastric GISTs in regards to short- and long-term outcomes. In selective patients, LAP is preferable compared with OPEN for its minimally invasive advantages. More well-designed RCTs or prospective cohort studies are awaited to adequately evaluate the status of laparoscopic resection for gastric GISTs.

Acknowledgements

This work was supported by the Department of Health of Zhejiang Province, China (grant number 2012ZDA024) and the Department of Education of Zhejiang Province, China (grant number Y201224313).
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

QLC and YP wrote the manuscript; JQC, DW and KC performed the literature review and conducted the analysis of pooled data; YPM proofread and revised the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Miettinen M, Majidi M, Lasota J: Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002, 38 (Suppl 5): S39-51.CrossRefPubMed Miettinen M, Majidi M, Lasota J: Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer. 2002, 38 (Suppl 5): S39-51.CrossRefPubMed
2.
Zurück zum Zitat Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne J: NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010, 2: S1-41. quiz S42-44 Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, Pisters PW, Raut CP, Riedel RF, Schuetze S, Sundar HM, Trent JC, Wayne J: NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010, 2: S1-41. quiz S42-44
3.
Zurück zum Zitat Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002, 33: 459-465.CrossRefPubMed Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW: Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002, 33: 459-465.CrossRefPubMed
4.
Zurück zum Zitat DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000, 231: 51-58.PubMedCentralCrossRefPubMed DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF: Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000, 231: 51-58.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Piso P, Schlitt HJ, Klempnauer J: Stromal sarcoma of the stomach: therapeutic considerations. Eur J Surg. 2000, 166: 954-958.CrossRefPubMed Piso P, Schlitt HJ, Klempnauer J: Stromal sarcoma of the stomach: therapeutic considerations. Eur J Surg. 2000, 166: 954-958.CrossRefPubMed
6.
Zurück zum Zitat Xu X, Chen K, Zhou W, Zhang R, Wang J, Wu D, Mou Y: Laparoscopic transgastric resection of gastric submucosal tumors located near the esophagogastric junction. J Gastrointest Surg. 2013, 17: 1570-1575.CrossRefPubMed Xu X, Chen K, Zhou W, Zhang R, Wang J, Wu D, Mou Y: Laparoscopic transgastric resection of gastric submucosal tumors located near the esophagogastric junction. J Gastrointest Surg. 2013, 17: 1570-1575.CrossRefPubMed
7.
Zurück zum Zitat Kang WM, Yu JC, Ma ZQ, Zhao ZR, Meng QB, Ye X: Laparoscopic-endoscopic cooperative surgery for gastric submucosal tumors. World J Gastroenterol. 2013, 19: 5720-5726.PubMedCentralCrossRefPubMed Kang WM, Yu JC, Ma ZQ, Zhao ZR, Meng QB, Ye X: Laparoscopic-endoscopic cooperative surgery for gastric submucosal tumors. World J Gastroenterol. 2013, 19: 5720-5726.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Valle M, Federici O, Carboni F, Carpano S, Benedetti M, Garofalo A: Gastrointestinal stromal tumors of the stomach: the role of laparoscopic resection. Single-centre experience of 38 cases. Surg Endosc. 2014, 28: 1040-1047.CrossRefPubMed Valle M, Federici O, Carboni F, Carpano S, Benedetti M, Garofalo A: Gastrointestinal stromal tumors of the stomach: the role of laparoscopic resection. Single-centre experience of 38 cases. Surg Endosc. 2014, 28: 1040-1047.CrossRefPubMed
9.
Zurück zum Zitat Lee CH, Hyun MH, Kwon YJ, Cho SI, Park SS: Deciding laparoscopic approaches for wedge resection in gastric submucosal tumors: a suggestive flow chart using three major determinants. J Am Coll Surg. 2012, 215: 831-840.CrossRefPubMed Lee CH, Hyun MH, Kwon YJ, Cho SI, Park SS: Deciding laparoscopic approaches for wedge resection in gastric submucosal tumors: a suggestive flow chart using three major determinants. J Am Coll Surg. 2012, 215: 831-840.CrossRefPubMed
10.
Zurück zum Zitat Grobmyer SR, Pieracci FM, Allen PJ, Brennan MF, Jaques DP: Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg. 2007, 204: 356-364.CrossRefPubMed Grobmyer SR, Pieracci FM, Allen PJ, Brennan MF, Jaques DP: Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg. 2007, 204: 356-364.CrossRefPubMed
11.
Zurück zum Zitat Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005, 5: 13-PubMedCentralCrossRefPubMed Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005, 5: 13-PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 117-188.CrossRef DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 117-188.CrossRef
14.
Zurück zum Zitat Basu S, Balaji S, Bennett DH, Davies N: Gastrointestinal stromal tumors (GIST) and laparoscopic resection. Surg Endosc. 2007, 21: 1685-1689.CrossRefPubMed Basu S, Balaji S, Bennett DH, Davies N: Gastrointestinal stromal tumors (GIST) and laparoscopic resection. Surg Endosc. 2007, 21: 1685-1689.CrossRefPubMed
15.
Zurück zum Zitat Chen YH, Liu KH, Yeh CN, Hsu JT, Liu YY, Tsai CY, Chiu CT, Jan YY, Yeh TS: Laparoscopic resection of gastrointestinal stromal tumors: safe, efficient, and comparable oncologic outcomes. J Laparoendosc Adv Surg Tech A. 2012, 22: 7587-7563. Chen YH, Liu KH, Yeh CN, Hsu JT, Liu YY, Tsai CY, Chiu CT, Jan YY, Yeh TS: Laparoscopic resection of gastrointestinal stromal tumors: safe, efficient, and comparable oncologic outcomes. J Laparoendosc Adv Surg Tech A. 2012, 22: 7587-7563.
16.
Zurück zum Zitat Fisher SB, Kim SC, Kooby DA, Cardona K, Russell MC, Delman KA, Staley CA, Maithel SK: Gastrointestinal stromal tumors: a single institution experience of 176 surgical patients. Am Surg. 2013, 79: 657-665.PubMed Fisher SB, Kim SC, Kooby DA, Cardona K, Russell MC, Delman KA, Staley CA, Maithel SK: Gastrointestinal stromal tumors: a single institution experience of 176 surgical patients. Am Surg. 2013, 79: 657-665.PubMed
17.
Zurück zum Zitat Otani Y, Furukawa T, Yoshida M, Saikawa Y, Wada N, Ueda M, Kubota T, Mukai M, Kameyama K, Sugino Y, Kumai K, Kitajima M: Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. Surgery. 2006, 139: 484-492.CrossRefPubMed Otani Y, Furukawa T, Yoshida M, Saikawa Y, Wada N, Ueda M, Kubota T, Mukai M, Kameyama K, Sugino Y, Kumai K, Kitajima M: Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. Surgery. 2006, 139: 484-492.CrossRefPubMed
18.
Zurück zum Zitat Wu JM, Yang CY, Wang MY, Wu MH, Lin MT: Gasless laparoscopy-assisted versus open resection for gastrointestinal stromal tumors of the upper stomach: preliminary results. J Laparoendosc Adv Surg Tech A. 2010, 20: 725-729.CrossRefPubMed Wu JM, Yang CY, Wang MY, Wu MH, Lin MT: Gasless laparoscopy-assisted versus open resection for gastrointestinal stromal tumors of the upper stomach: preliminary results. J Laparoendosc Adv Surg Tech A. 2010, 20: 725-729.CrossRefPubMed
20.
Zurück zum Zitat Shimizu S, Noshiro H, Nagai E, Uchiyama A, Mizumoto K, Tanaka M: Laparoscopic wedge resection of gastric submucosal tumors. Dig Surg. 2002, 19: 169-173.CrossRefPubMed Shimizu S, Noshiro H, Nagai E, Uchiyama A, Mizumoto K, Tanaka M: Laparoscopic wedge resection of gastric submucosal tumors. Dig Surg. 2002, 19: 169-173.CrossRefPubMed
21.
Zurück zum Zitat Matthews BD, Walsh RM, Kercher KW, Sing RF, Pratt BL, Answini GA, Heniford BT: Laparoscopic vs open resection of gastric stromal tumors. Surg Endosc. 2002, 16: 803-807.CrossRefPubMed Matthews BD, Walsh RM, Kercher KW, Sing RF, Pratt BL, Answini GA, Heniford BT: Laparoscopic vs open resection of gastric stromal tumors. Surg Endosc. 2002, 16: 803-807.CrossRefPubMed
22.
Zurück zum Zitat Ishikawa K, Inomata M, Etoh T, Shiromizu A, Shiraishi N, Arita T, Kitano S: Long-term outcome of laparoscopic wedge resection for gastric submucosal tumor compared with open wedge resection. Surg Laparosc Endosc Percutan Tech. 2006, 16: 82-85.CrossRefPubMed Ishikawa K, Inomata M, Etoh T, Shiromizu A, Shiraishi N, Arita T, Kitano S: Long-term outcome of laparoscopic wedge resection for gastric submucosal tumor compared with open wedge resection. Surg Laparosc Endosc Percutan Tech. 2006, 16: 82-85.CrossRefPubMed
23.
Zurück zum Zitat Mochizuki Y, Kodera Y, Fujiwara M, Ito S, Yamamura Y, Sawaki A, Yamao K, Kato T: Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experience. Surg Today. 2006, 36: 341-347.CrossRefPubMed Mochizuki Y, Kodera Y, Fujiwara M, Ito S, Yamamura Y, Sawaki A, Yamao K, Kato T: Laparoscopic wedge resection for gastrointestinal stromal tumors of the stomach: initial experience. Surg Today. 2006, 36: 341-347.CrossRefPubMed
24.
Zurück zum Zitat Nishimura J, Nakajima K, Omori T, Takahashi T, Nishitani A, Ito T, Nishida T: Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection. Surg Endosc. 2007, 21: 875-878.CrossRefPubMed Nishimura J, Nakajima K, Omori T, Takahashi T, Nishitani A, Ito T, Nishida T: Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection. Surg Endosc. 2007, 21: 875-878.CrossRefPubMed
25.
Zurück zum Zitat Pitsinis V, Khan AZ: Cranshaw I. Allum WH: Single center experience of laparoscopic vs. open resection for gastrointestinal stromal tumors of the stomach. Hepatogastroenterology. 2007, 54: 606-608.PubMed Pitsinis V, Khan AZ: Cranshaw I. Allum WH: Single center experience of laparoscopic vs. open resection for gastrointestinal stromal tumors of the stomach. Hepatogastroenterology. 2007, 54: 606-608.PubMed
26.
Zurück zum Zitat Catena F, Di Battista M, Fusaroli P, Ansaloni L, Di Scioscio V, Santini D, Pantaleo M, Biasco G, Caletti G, Pinna A: Laparoscopic treatment of gastric GIST: report of 21 cases and literature’s review. J Gastrointest Surg. 2008, 12: 561-568.CrossRefPubMed Catena F, Di Battista M, Fusaroli P, Ansaloni L, Di Scioscio V, Santini D, Pantaleo M, Biasco G, Caletti G, Pinna A: Laparoscopic treatment of gastric GIST: report of 21 cases and literature’s review. J Gastrointest Surg. 2008, 12: 561-568.CrossRefPubMed
27.
Zurück zum Zitat Silberhumer GR, Hufschmid M, Wrba F, Gyoeri G, Schoppmann S, Tribl B, Wenzl E, Prager G, Laengle F, Zacherl J: Surgery for gastrointestinal stromal tumors of the stomach. J Gastrointest Surg. 2009, 13: 1213-1219.CrossRefPubMed Silberhumer GR, Hufschmid M, Wrba F, Gyoeri G, Schoppmann S, Tribl B, Wenzl E, Prager G, Laengle F, Zacherl J: Surgery for gastrointestinal stromal tumors of the stomach. J Gastrointest Surg. 2009, 13: 1213-1219.CrossRefPubMed
28.
Zurück zum Zitat Goh BK, Chow PK, Chok AY, Chan WH, Chung YF, Ong HS, Wong WK: Impact of the introduction of laparoscopic wedge resection as a surgical option for suspected small/medium-sized gastrointestinal stromal tumors of the stomach on perioperative and oncologic outcomes. World J Surg. 2010, 34: 1847-1852.CrossRefPubMed Goh BK, Chow PK, Chok AY, Chan WH, Chung YF, Ong HS, Wong WK: Impact of the introduction of laparoscopic wedge resection as a surgical option for suspected small/medium-sized gastrointestinal stromal tumors of the stomach on perioperative and oncologic outcomes. World J Surg. 2010, 34: 1847-1852.CrossRefPubMed
29.
Zurück zum Zitat Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, DeMatteo RP, Strong VE: Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol. 2011, 18: 1599-1605.CrossRefPubMed Karakousis GC, Singer S, Zheng J, Gonen M, Coit D, DeMatteo RP, Strong VE: Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol. 2011, 18: 1599-1605.CrossRefPubMed
30.
Zurück zum Zitat Dai QQ, Ye ZY, Zhang W, Lv ZY, Shao QS, Sun YS, Tao HQ: Laparoscopic versus open wedge resection for gastrointestinal stromal tumors of the stomach: a clinical controlled study. Chin J Gastrointest Surg. 2011, 14: 603-605. Dai QQ, Ye ZY, Zhang W, Lv ZY, Shao QS, Sun YS, Tao HQ: Laparoscopic versus open wedge resection for gastrointestinal stromal tumors of the stomach: a clinical controlled study. Chin J Gastrointest Surg. 2011, 14: 603-605.
31.
Zurück zum Zitat De Vogelaere K, Hoorens A, Haentjens P, Delvaux G: Laparoscopic versus open resection of gastrointestinal stromal tumors of the stomach. Surg Endosc. 2013, 27: 1546-1554.CrossRefPubMed De Vogelaere K, Hoorens A, Haentjens P, Delvaux G: Laparoscopic versus open resection of gastrointestinal stromal tumors of the stomach. Surg Endosc. 2013, 27: 1546-1554.CrossRefPubMed
32.
Zurück zum Zitat Melstrom LG, Phillips JD, Bentrem DJ, Wayne JD: Laparoscopic versus open resection of gastric gastrointestinal stromal tumors. Am J Clin Oncol. 2012, 35: 451-454.CrossRefPubMed Melstrom LG, Phillips JD, Bentrem DJ, Wayne JD: Laparoscopic versus open resection of gastric gastrointestinal stromal tumors. Am J Clin Oncol. 2012, 35: 451-454.CrossRefPubMed
33.
Zurück zum Zitat Lee HH, Hur H, Jung H, Park CH, Jeon HM, Song KY: Laparoscopic wedge resection for gastric submucosal tumors: a size-location matched case-control study. J Am Coll Surg. 2011, 212: 195-199.CrossRefPubMed Lee HH, Hur H, Jung H, Park CH, Jeon HM, Song KY: Laparoscopic wedge resection for gastric submucosal tumors: a size-location matched case-control study. J Am Coll Surg. 2011, 212: 195-199.CrossRefPubMed
34.
Zurück zum Zitat Wan P, Yan C, Li C, Yan M, Zhu ZG: Choices of surgical approaches for gastrointestinal stromal tumors of the stomach: laparoscopic versus open resection. Dig Surg. 2012, 29: 243-250.CrossRefPubMed Wan P, Yan C, Li C, Yan M, Zhu ZG: Choices of surgical approaches for gastrointestinal stromal tumors of the stomach: laparoscopic versus open resection. Dig Surg. 2012, 29: 243-250.CrossRefPubMed
35.
Zurück zum Zitat Pucci MJ, Berger AC, Lim PW, Chojnacki KA, Rosato EL, Palazzo F: Laparoscopic approaches to gastric gastrointestinal stromal tumors: an institutional review of 57 cases. Surg Endosc. 2012, 26: 3509-3514.CrossRefPubMed Pucci MJ, Berger AC, Lim PW, Chojnacki KA, Rosato EL, Palazzo F: Laparoscopic approaches to gastric gastrointestinal stromal tumors: an institutional review of 57 cases. Surg Endosc. 2012, 26: 3509-3514.CrossRefPubMed
36.
Zurück zum Zitat Kim KH, Kim MC, Jung GJ, Kim SJ, Jang JS, Kwon HC: Long term survival results for gastric GIST: is laparoscopic surgery for large gastric GIST feasible?. World J Surg Oncol. 2012, 10: 230-PubMedCentralCrossRefPubMed Kim KH, Kim MC, Jung GJ, Kim SJ, Jang JS, Kwon HC: Long term survival results for gastric GIST: is laparoscopic surgery for large gastric GIST feasible?. World J Surg Oncol. 2012, 10: 230-PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Shu ZB, Sun LB, Li JP, Li YC, Ding DY: Laparoscopic versus open resection of gastric gastrointestinal stromal tumors. Chin J Cancer Res. 2013, 25: 175-182.PubMedCentralPubMed Shu ZB, Sun LB, Li JP, Li YC, Ding DY: Laparoscopic versus open resection of gastric gastrointestinal stromal tumors. Chin J Cancer Res. 2013, 25: 175-182.PubMedCentralPubMed
38.
Zurück zum Zitat Lee PC, Lai PS, Yang CY, Chen CN, Lai IR, Lin MT: A gasless laparoscopic technique of wide excision for gastric gastrointestinal stromal tumor versus open method. World J Surg Oncol. 2013, 11: 44-PubMedCentralCrossRefPubMed Lee PC, Lai PS, Yang CY, Chen CN, Lai IR, Lin MT: A gasless laparoscopic technique of wide excision for gastric gastrointestinal stromal tumor versus open method. World J Surg Oncol. 2013, 11: 44-PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Kasetsermwiriya W, Nagai E, Nakata K, Nagayoshi Y, Shimizu S, Tanaka M: Laparoscopic surgery for gastric gastrointestinal stromal tumor is feasible irrespective of tumor size. J Laparoendosc Adv Surg Tech A. 2014, 24: 123-129.CrossRefPubMed Kasetsermwiriya W, Nagai E, Nakata K, Nagayoshi Y, Shimizu S, Tanaka M: Laparoscopic surgery for gastric gastrointestinal stromal tumor is feasible irrespective of tumor size. J Laparoendosc Adv Surg Tech A. 2014, 24: 123-129.CrossRefPubMed
40.
Zurück zum Zitat Lin J, Huang C, Zheng C, Li P, Xie J, Wang J, Lu J: Laparoscopic versus open gastric resection for larger than 5 cm primary gastric gastrointestinal stromal tumors (GIST): a size-matched comparison. Surg Endosc. 2014, [Epub ahead of print] Lin J, Huang C, Zheng C, Li P, Xie J, Wang J, Lu J: Laparoscopic versus open gastric resection for larger than 5 cm primary gastric gastrointestinal stromal tumors (GIST): a size-matched comparison. Surg Endosc. 2014, [Epub ahead of print]
41.
Zurück zum Zitat Takahashi T, Nakajima K, Miyazaki Y, Miyazaki Y, Kurokawa Y, Yamasaki M, Miyata H, Takiguchi S, Nishida T, Mori M, Doki Y: Surgical strategy for the gastric gastrointestinal stromal tumors (GISTs) larger than 5 cm: laparoscopic surgery is feasible, safe, and oncologically acceptable. Surg Laparosc Endosc Percutan Tech. 2014, [Epub ahead of print] Takahashi T, Nakajima K, Miyazaki Y, Miyazaki Y, Kurokawa Y, Yamasaki M, Miyata H, Takiguchi S, Nishida T, Mori M, Doki Y: Surgical strategy for the gastric gastrointestinal stromal tumors (GISTs) larger than 5 cm: laparoscopic surgery is feasible, safe, and oncologically acceptable. Surg Laparosc Endosc Percutan Tech. 2014, [Epub ahead of print]
42.
Zurück zum Zitat Miettinen M, El-Rifai WHL, Sobin L, Lasota J: Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002, 33: 478-483.CrossRefPubMed Miettinen M, El-Rifai WHL, Sobin L, Lasota J: Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol. 2002, 33: 478-483.CrossRefPubMed
43.
Zurück zum Zitat Koh YX, Chok AY, Zheng HL, Tan CS, Chow PK, Wong WK, Goh BK: A systematic review and meta-analysis comparing laparoscopic versus open gastric resections for gastrointestinal stromal tumors of the stomach. Ann Surg Oncol. 2013, 20: 3549-3560.CrossRefPubMed Koh YX, Chok AY, Zheng HL, Tan CS, Chow PK, Wong WK, Goh BK: A systematic review and meta-analysis comparing laparoscopic versus open gastric resections for gastrointestinal stromal tumors of the stomach. Ann Surg Oncol. 2013, 20: 3549-3560.CrossRefPubMed
44.
Zurück zum Zitat Chen K, Zhou YC, Mou YP, Xu XW, Jin WW, Ajoodhea H: Systematic review and meta-analysis of safety and efficacy of laparoscopic resection for gastrointestinal stromal tumors of the stomach. Surg Endosc. 2014, [Epub ahead of print] Chen K, Zhou YC, Mou YP, Xu XW, Jin WW, Ajoodhea H: Systematic review and meta-analysis of safety and efficacy of laparoscopic resection for gastrointestinal stromal tumors of the stomach. Surg Endosc. 2014, [Epub ahead of print]
45.
Zurück zum Zitat Ephgrave KS, Kleiman-Wexler R, Pfaller M, Booth B, Werkmeister L, Young S: Postoperative pneumonia: a prospective study of risk factors and morbidity. Surgery. 1993, 114: 815-819. discussion 819-821PubMed Ephgrave KS, Kleiman-Wexler R, Pfaller M, Booth B, Werkmeister L, Young S: Postoperative pneumonia: a prospective study of risk factors and morbidity. Surgery. 1993, 114: 815-819. discussion 819-821PubMed
46.
Zurück zum Zitat Chen K, Xu XW, Zhang RC, Pan Y, Wu D, Mou YP: Systematic review and meta-analysis of laparoscopy-assisted and open total gastrectomy for gastric cancer. World J Gastroenterol. 2013, 19: 5365-5376.PubMedCentralCrossRefPubMed Chen K, Xu XW, Zhang RC, Pan Y, Wu D, Mou YP: Systematic review and meta-analysis of laparoscopy-assisted and open total gastrectomy for gastric cancer. World J Gastroenterol. 2013, 19: 5365-5376.PubMedCentralCrossRefPubMed
47.
Zurück zum Zitat Xie K, Zhu YP, Xu XW, Chen K, Yan JF, Mou YP: Laparoscopic distal pancreatectomy is as safe and feasible as open procedure: a meta-analysis. World J Gastroenterol. 2012, 18: 1959-1967.PubMedCentralCrossRefPubMed Xie K, Zhu YP, Xu XW, Chen K, Yan JF, Mou YP: Laparoscopic distal pancreatectomy is as safe and feasible as open procedure: a meta-analysis. World J Gastroenterol. 2012, 18: 1959-1967.PubMedCentralCrossRefPubMed
48.
Zurück zum Zitat Law WL, Lee YM, Choi HK, Seto CL, Ho JW: Impact of laparoscopic resection for colorectal cancer on operative outcomes and survival. Ann Surg. 2007, 245: 1-7.PubMedCentralCrossRefPubMed Law WL, Lee YM, Choi HK, Seto CL, Ho JW: Impact of laparoscopic resection for colorectal cancer on operative outcomes and survival. Ann Surg. 2007, 245: 1-7.PubMedCentralCrossRefPubMed
49.
Zurück zum Zitat Chen K, Mou YP, Xu XW, Cai JQ, Wu D, Pan Y, Zhang RC: Short-term surgical and long-term survival outcomes after laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer. BMC Gastroenterol. 2014, 14: 41-PubMedCentralCrossRefPubMed Chen K, Mou YP, Xu XW, Cai JQ, Wu D, Pan Y, Zhang RC: Short-term surgical and long-term survival outcomes after laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer. BMC Gastroenterol. 2014, 14: 41-PubMedCentralCrossRefPubMed
Metadaten
Titel
Laparoscopic versus open resection for gastric gastrointestinal stromal tumors: an updated systematic review and meta-analysis
verfasst von
Qi-Long Chen
Yu Pan
Jia-Qin Cai
Di Wu
Ke Chen
Yi-Ping Mou
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2014
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-12-206

Weitere Artikel der Ausgabe 1/2014

World Journal of Surgical Oncology 1/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.